(1 - 11 von 11
)
EMBL-Cancer Core Europe Conference - Cancer Immunotherapy - Programme
www.embl.de
Dietmar Zehn, Technical University Munich. 15:45-16:15: Targeting the driver mutation IDH1R132H in brain tumors Michael Platten, German Cancer Research Institute: 16:15-17:00: Coffee Break (kindly sponsored by Roche) & Meet the Speakers: 17:00-17:30: What do T cells recognize on tumor cells? John Haanen, Netherlands Cancer Institute: 17:30-17:45
sortiert nach Relevanz / Datum